You are here
,

U.S. FDA approves Lilly migraine drug; price same as rivals

  • Friday, 28 September 2018
  • Posted by Aftab Ahmad
  • 0 Comments
Eli Lilly and Co on Thursday said the U.S. Food and Drug Administration approved its migraine drug Emgality, marking the third approval from a promising new class of treatments for the often debilitating headaches.


from Reuters: Health News https://ift.tt/2Qa6vyG

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply